Join the club for FREE to access the whole archive and other member benefits.
Juvenescence Ltd is making investments in the future of rejuvenation and life extension technology
Key points from article :
Wrote "Juvenescence: Investing in the Age of Longevity" in 2017.
Believes that some people today will live to be over 150.
Juvenescence Ltd. has raised $62.5m and invested in 9 biotech companies.
Some technologies now in the process of phase 3 human trials.
Drugs become much cheaper after 10 year patents expire.
Personal supplement regime includes metformin, NMR precursors and mini aspirin.
Click on resource name for more details.
Biotechnology company that uses artificial intelligence to develop new drugs and for aging research
British entrepreneur, author and philanthropist with interests across a number of industries
The book written by Jim Mellon & Al Chalabi investigates the new technologies and explains how to benefit from the life extending technologies
